Chilton Capital Management LLC Increases Stock Position in Corteva, Inc. $CTVA

Chilton Capital Management LLC boosted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 1.2% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 376,970 shares of the company’s stock after buying an additional 4,324 shares during the quarter. Chilton Capital Management LLC’s holdings in Corteva were worth $28,096,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently modified their holdings of the stock. Brighton Jones LLC increased its stake in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after acquiring an additional 11,760 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Corteva by 15.0% during the first quarter. GAMMA Investing LLC now owns 15,061 shares of the company’s stock valued at $948,000 after purchasing an additional 1,962 shares during the period. Cambridge Investment Research Advisors Inc. increased its position in shares of Corteva by 12.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 49,377 shares of the company’s stock worth $3,107,000 after acquiring an additional 5,456 shares during the period. Golden State Wealth Management LLC lifted its holdings in shares of Corteva by 322.7% in the 1st quarter. Golden State Wealth Management LLC now owns 2,388 shares of the company’s stock worth $150,000 after buying an additional 1,823 shares during the period. Finally, Pure Financial Advisors LLC increased its position in Corteva by 39.1% during the 1st quarter. Pure Financial Advisors LLC now owns 5,041 shares of the company’s stock valued at $317,000 after purchasing an additional 1,417 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Up 0.2%

Shares of CTVA opened at $63.63 on Friday. The company has a market capitalization of $43.21 billion, a price-to-earnings ratio of 31.04, a PEG ratio of 1.46 and a beta of 0.76. Corteva, Inc. has a 52 week low of $53.40 and a 52 week high of $77.41. The stock’s 50-day moving average price is $68.53 and its 200-day moving average price is $69.13. The company has a quick ratio of 1.23, a current ratio of 1.68 and a debt-to-equity ratio of 0.06.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $2.20 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.31. Corteva had a return on equity of 8.68% and a net margin of 8.16%.The business had revenue of $6.46 billion during the quarter, compared to analysts’ expectations of $6.26 billion. During the same period in the previous year, the business earned $1.83 earnings per share. The business’s revenue was up 5.6% compared to the same quarter last year. On average, sell-side analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, September 15th. Investors of record on Tuesday, September 2nd were given a dividend of $0.18 per share. This is a boost from Corteva’s previous quarterly dividend of $0.17. The ex-dividend date was Tuesday, September 2nd. This represents a $0.72 annualized dividend and a dividend yield of 1.1%. Corteva’s payout ratio is currently 35.12%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CTVA. Royal Bank Of Canada lowered their target price on Corteva from $86.00 to $80.00 and set an “outperform” rating for the company in a report on Friday, October 17th. Argus lowered their price target on shares of Corteva from $83.00 to $80.00 and set a “buy” rating on the stock in a report on Monday, October 13th. Oppenheimer reduced their target price on Corteva from $87.00 to $75.00 and set an “outperform” rating on the stock in a research report on Wednesday. Morgan Stanley set a $84.00 price objective on shares of Corteva in a report on Monday, September 15th. Finally, Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 1st. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $79.94.

Insiders Place Their Bets

In related news, EVP Robert D. King sold 37,280 shares of Corteva stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $74.20, for a total value of $2,766,176.00. Following the sale, the executive vice president directly owned 49,262 shares in the company, valued at approximately $3,655,240.40. The trade was a 43.08% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.14% of the company’s stock.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.